1. Home
  2. KYMR vs TSLX Comparison

KYMR vs TSLX Comparison

Compare KYMR & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • TSLX
  • Stock Information
  • Founded
  • KYMR 2015
  • TSLX 2010
  • Country
  • KYMR United States
  • TSLX United States
  • Employees
  • KYMR N/A
  • TSLX N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • TSLX Investment Managers
  • Sector
  • KYMR Health Care
  • TSLX Finance
  • Exchange
  • KYMR Nasdaq
  • TSLX Nasdaq
  • Market Cap
  • KYMR 2.2B
  • TSLX 1.9B
  • IPO Year
  • KYMR 2020
  • TSLX 2014
  • Fundamental
  • Price
  • KYMR $25.97
  • TSLX $20.43
  • Analyst Decision
  • KYMR Buy
  • TSLX Strong Buy
  • Analyst Count
  • KYMR 13
  • TSLX 6
  • Target Price
  • KYMR $56.69
  • TSLX $23.17
  • AVG Volume (30 Days)
  • KYMR 847.3K
  • TSLX 649.9K
  • Earning Date
  • KYMR 05-01-2025
  • TSLX 04-30-2025
  • Dividend Yield
  • KYMR N/A
  • TSLX 10.28%
  • EPS Growth
  • KYMR N/A
  • TSLX N/A
  • EPS
  • KYMR N/A
  • TSLX 2.03
  • Revenue
  • KYMR $47,072,000.00
  • TSLX $482,526,000.00
  • Revenue This Year
  • KYMR $16.24
  • TSLX N/A
  • Revenue Next Year
  • KYMR $22.41
  • TSLX $0.65
  • P/E Ratio
  • KYMR N/A
  • TSLX $10.08
  • Revenue Growth
  • KYMR N/A
  • TSLX 10.14
  • 52 Week Low
  • KYMR $19.45
  • TSLX $18.58
  • 52 Week High
  • KYMR $53.27
  • TSLX $23.67
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 44.70
  • TSLX 41.67
  • Support Level
  • KYMR $24.43
  • TSLX $19.29
  • Resistance Level
  • KYMR $26.06
  • TSLX $20.36
  • Average True Range (ATR)
  • KYMR 2.36
  • TSLX 0.75
  • MACD
  • KYMR 0.41
  • TSLX -0.06
  • Stochastic Oscillator
  • KYMR 70.12
  • TSLX 45.68

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

Share on Social Networks: